Skip to main content

Table 5 The total number of registered and reregistered veterinary pharmaceutical in Jordan between 2017-2020

From: The role of veterinarians in the One Health approach to antimicrobial resistance perspectives in Jordan

Antimicrobial

Produced

Imported

2017

2018

2019

2020

2017

2018

2019

2020

Antibiotic ( Per Oral)

 Aminoglycoside

3

4

2

0

1

2

2

0

 Cepaholsporin (cefalexin)

0

0

0

0

0

1

0

0

 Fosfomycin

0

1

1

0

0

0

1

0

 Ionophores

0

0

0

0

0

1

0

2

 Lincosamid

0

0

0

0

0

0

2

0

 Macrolides

1

6

2

2

4

4

3

5

 Penicillin’s

1

3

3

1

3

0

1

3

 Phenicol’s

3

5

3

0

1

0

0

0

 Pleuromutilin’s

0

0

0

0

0

0

0

2

 Polypeptide

2

3

1

1

2

1

1

1

 Quinolones

2

7

5

1

2

2

3

1

 Sulfonamides

3

4

6

4

0

0

1

0

 Fluoroquinolones

0

0

 

0

0

0

0

0

 Tetracycline

4

6

2

1

2

0

7

1

 More than one active material

2

10

14

4

3

5

6

0

 Percentage per Year

19.09%

32.67%

23.35%

15.38%

16.36%

10.66%

16.16%

16.48%

Antibiotic (Parental)

 Aminoglycoside

1

0

1

0

2

0

1

2

 Cephalosporin

0

0

1

1

2

1

2

5

 Macrolides

0

0

2

1

5

0

5

2

 Penicillin’s

1

1

0

0

4

0

2

0

 Phenicol’s

0

0

4

0

2

2

2

2

 Quinolones

0

0

3

0

1

2

1

3

 Sulfonamides

1

0

1

0

0

0

2

1

 Tetracycline

1

2

11

0

9

5

9

4

 More than one active material

1

1

3

0

4

3

6

4

 Percentage per year

4.55%

2.67%

15.57%

2.20%

26.36%

8.66%

17.96%

25.27%

Antibiotic Intramammary a

 Total

1

0

0

0

0

0

0

0

 Percentage per year

0.00%

0.67%

1.20%

0.00%

2.73%

0.66%

0.00%

0.00%

Antiparasitic

 Ectoparasite b

10

15

7

12

1

7

3

3

 Anticoccidial c

0

3

3

3

7

1

2

2

 Antiprotozoal d

0

1

1

0

0

0

0

0

 Anthelmintics e

8

22

15

9

7

15

11

8

 Percentage per year

16.36%

27.33%

15.57%

26.37%

13.64%

15.33%

9.58%

14.28%

Alternative to antibiotics f

 Percentage per year

0.00%

1.33%

0.60%

0.00%

0.91%

0.00%

0.00%

0.00%

  1. Note. The following are the main active material of the mentioned pharmaceutical product:
  2. aCefalonium, Lincomycin hydrochloride and Neomycin sulfate, Benzathine and Ampicillin trihydrate, Cefalexin monohydrate and Gentamycin sulfate, Oxytetracycline and Neomycin
  3. b Afoxolaner, Milbemycin oxime, Clopidol, Fenvalarate, Permethrin, Fipronil, Lambda cyhalothrin Flumethrin, Cyromazin, Alphacypermethrin, Imidacloprid, Organophosphates, and Amitraz
  4. c Clopidol, Narasin, Narasin-Nicarbazin, Diclazuril, Toltrazuril, and Sulphaquinoxaline
  5. d Diminazen
  6. e Ivermectin, Eprinomectin, Rafoxanide, Oxyclozanide, Tinidazole, Netobimin, Oxfendazole, Flubendazole, Amprolium, Albendazole, Levamisole, Tetramisole, and Fenbendazole
  7. f Thymol, Menthol, Eucalyptus oil and Artichoke Extract